Targeted biopsy of suspected prostate cancer (PCa) lesions, identified using magnetic resonance-ultrasound (MR-US) fusion, increases PCa detection and detects aggressive tumors that may be missed by conventional biopsy, according to a study published in The Journal of Urology (2012;189:86-92). Read the Article.
MR-US Fusion Targeted Biopsy Boosts Detection of Prostate Cancer Read More »
A medical researcher with the University of Alberta and his team just published their findings about their work on developing ‘homing beacon drugs’ that kill only cancer cells, not healthy ones, thanks to nano-technology. Read More.
‘Homing Beacon Drugs’ to Target Cancer Cells Read More »
Dr. Patrick Lee, PhD Professor Department of Microbiology & Immunology Faculty of Medicine Dalhousie University, Halifax, NS, Canada Dr. Lee’s approach to the treatment of prostate cancer is evolutionary, forward-looking, and revolutionary: a focus on the reovirus, a naturally-occuring benign human virus. The reovirus is used directly to infect cancer cells and indirectly to activate the body’s immune system against cancer cells. Dr. Lee’s presentation at the October 2011 PCC Conference in Halifax was a definite highlight and we are thrilled that he was our special Prostate Cancer Week Awareness Night speaker. CLICK ON THE ARROW TO START
VIDEO: Dr. Patrick Lee PhD, “Using viruses to target Prostate Cancer.” Read More »
A diabetes drug costing as little as 2p a tablet could offer a major breakthrough in the treatment of prostate cancer. Research has shown that the medicine, called metformin, causes tumours to shrink by slowing the rate at which cancerous cells grow. Read the article
Metformin, a diabetes drug, shrinks prostate tumours Read More »
Prostate cancer protein discovered by scientists could lead to new tests and treatments * The protein is found in aggressive forms of the cancer * Scientist believe they can use the protein as a marker, providing a potential new target for drug treatment Read More
Protein Marker for Aggressive Prostate Cancer Read More »
Dr. Rajiv Singal MD, FRCSC Head, Division of Urology, Toronto East General Hospital Lecturer, Department of Surgery, University of Toronto Supervisor, Clinical Endourology and Minimally Invasive Fellowship, Toronto East General Hospital Toronto, Canada Prostate cancer remains a uniquely challenging disease. It is very common and its clinical consequences range from harmless to lethal. The challenge remains to try to distinguish between these two ends of the spectrum. Doing so will allow us to better tailor treatment, to avoid significant side effects when not necessary, and to intervene early when an individual is at risk. CLICK ON THE
Toronto’s medical community is buzzing about an invention that could change the way health professionals screen for infectious disease and cancer. “We’ve been working on this, really, for about a decade,” said Dr. Shana Kelley, a scientist at the University of Toronto. Kelley spoke as she held a small black device her hand, shaped like a smartphone but bulkier, with a microchip inside that Kelley says can determine in 15 minutes if you have cancer or an infectious disease. Read more.
Diagnosis on a Microchip Read More »
Dr. Roger Buckley, Medical Director, Gale and Graham Wright Prostate Centre and Chief of Urology Dr. Denis MacDonald, Chief Pathologist and Director of Laboratories, Department of Laboratory Medicine Dr. Irv Jacobs, Chief of Radiography Department North York General Hospital The Gale and Graham Wright Prostate Centre CLICK ON THE BLUE TEXT BELOW, TO SEE OUR VIDEOS
Prostate Cancer: To the biopsy and beyond Read More »
On Jan. 26, 2011 Dr. Robert Bristow, gave details of a International Reseach project to PCCN-Toronto’s Awareness Night, prior to it’s public announcement -The study of cancer genetics is unlocking the secrets of prostate cancer -These secrets will give rise to new diagnostic tests and new treatments within the next 10 years. -These will be personal secrets that can be used to individualize treatment for men with prostate cancer. -and more Feb. 15, 2011 from CBC News “Prostate cancer genome to be decoded” Prostate cancer’s genetic mutations will be mapped under a new $20 million Canadian research project that aims
Dr. Robert Bristow “Personalized Medicine in Prostate Cancer” Read More »
Click for questionDrugs or clinical trials for Cancer that seems hormone resistant? Click for questionWhat has been done to find the cause of cancer? Click for questionDoes an enlarged prostate lead to prostate cancer? Click for questionDoes aggresive mean fast growing? Click for questionPt. 1 Spot in pelvic area? Click for questionPt. 2 Would he be a candidate for Tookad? Click for questionDefect in cellular repair? Click for questionCompare surgery and radio therapy? How many newly diagnosed in GTA? more Click for questionConnection between your research and urine test? Click for questionIs the Protein PML part of your work? Click
Dr. Bristow Answers Questions Read More »